PubRank

B Wollenberg

Author PubWeight™ 35.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing. J Immunol 1999 1.52
2 In vivo perfusion analysis of normal and dysplastic ears and its implication on total auricular reconstruction. J Plast Reconstr Aesthet Surg 2008 1.39
3 The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells. Br J Cancer 2000 1.33
4 Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Scand J Immunol 2007 1.32
5 Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development. Br J Cancer 2010 1.03
6 Tumor cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1. FASEB J 2000 1.03
7 [Reconstruction of the auditory canal wall with bone chips from the temporal squama--preliminary results]. Laryngorhinootologie 2007 1.00
8 Reversed portal vein pulsatility on Doppler ultrasound secondary to an iatrogenic mediastinal haematoma. Br J Radiol 2001 0.96
9 High energy probe for detecting lymph node metastases with 18F-FDG in patients with head and neck cancer. Nuklearmedizin 2006 0.92
10 Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technology. Cell Mol Life Sci 2004 0.90
11 Tumor necrosis factor alpha negatively regulates the expression of the carcinoma-associated antigen epithelial cell adhesion molecule. Cancer 2001 0.90
12 [Clinical and epidemiological data of patients with malignomas of the head and neck]. Laryngorhinootologie 2002 0.89
13 Assessment of skills using a virtual reality temporal bone surgery simulator. Acta Otorhinolaryngol Ital 2013 0.89
14 Decline of lactate in tumor tissue after ketogenic diet: in vivo microdialysis study in patients with head and neck cancer. Nutr Cancer 2013 0.87
15 [Chronic pain therapy for patients with head and neck tumors]. HNO 2006 0.87
16 Absence of B7.1-CD28/CTLA-4-mediated co-stimulation in human NK cells. Eur J Immunol 1998 0.85
17 [Implementation of the new quality assurance agreement for the fitting of hearing aids in daily practice. Part 1: New regulations pertaining to hearing aid fitting]. HNO 2014 0.84
18 [Development and use of an APHAB database]. HNO 2014 0.84
19 [Implementation of the new quality assurance agreement for the fitting of hearing aids in daily practice. Part 2: New diagnostic aspects of speech audiometry]. HNO 2014 0.84
20 [Spontaneous retropharyngeal hematoma: a rare differential diagnosis of acute dysphagia]. HNO 2008 0.82
21 [Salivary gland carcinomas Part II. Diagnosis and therapy]. HNO 2005 0.81
22 [Incidence of Doppler ultrasound detectable stenoses of cervical arteries in patients with cochlear-vestibular symptoms]. Laryngorhinootologie 1993 0.81
23 The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck. Anticancer Res 2003 0.81
24 Changes in head and neck tumor hypoxic fraction during split-course radiochemotherapy. Ann Otol Rhinol Laryngol 1999 0.80
25 Botulinum toxin for Frey's syndrome: a closer look at different treatment responses. J Laryngol Otol 2011 0.80
26 Impairment of T-cell activation in head and neck cancer in situ and in vitro: strategies for an immune restoration. Arch Otolaryngol Head Neck Surg 1999 0.80
27 Localization of transforming growth factor-beta-expressing cells and comparison with major extracellular components in aural cholesteatoma. Ann Otol Rhinol Laryngol 1997 0.79
28 [Development of an ICF-based clinical practice guideline for the assessment of function in head and neck cancer]. Laryngorhinootologie 2013 0.78
29 Ep-CAM--a marker for the detection of disseminated tumor cells in patients suffering from SCCHN. Anticancer Res 1999 0.78
30 High-resolution ultrasonography in gastrointestinal graft-versus-host disease. Ann Hematol 2004 0.78
31 MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer. Anticancer Res 2003 0.78
32 [Application of skin adhesives in head and neck surgery: analysis of cosmetic results, applicability and cost-effectiveness of cyanoacrylate-based adhesives]. HNO 2008 0.78
33 Results in using the Freiburger monosyllabic speech test in noise without and with hearing aids. Eur Arch Otorhinolaryngol 2014 0.77
34 [A dural fistula as a rare cause for a pulse-synchronized tinnitus aurium]. Laryngorhinootologie 2008 0.77
35 [Unilateral extended medialization thyroplasty. Treatment for total aspiration after laser surgery and radiotherapy of laryngeal cancer]. HNO 2008 0.77
36 [Development of a computed tomography data-based Vibrant Bonebridge viewer]. HNO 2014 0.77
37 [Tracheal stents for esophagotracheal fistula in laryngectomy patients. Safe fixation to the tracheostoma]. HNO 2009 0.76
38 Partially reversed intrasplenic venous blood flow detected by color Doppler sonography in two patients with hematologic diseases and splenomegaly. J Clin Ultrasound 2001 0.76
39 [Brachytherapy in combination with function-preserving surgery. An interdisciplinary challenge]. HNO 2008 0.76
40 [Brachytherapy for the treatment of head and neck cancer]. HNO 2010 0.76
41 [Constitutive expression of the potential stem cell marker CD44 in permanent HNSCC cell lines]. HNO 2008 0.76
42 [In search of new treatment methods for head-neck carcinoma]. Laryngorhinootologie 1999 0.75
43 [The expression of zeta-chain of the T cell receptor as prognostic marker for patients with head and neck cancer]. Laryngorhinootologie 2002 0.75
44 [Treatment of chronic rhinosinusitis using balloon sinuplasty. A quality of life analysis]. HNO 2013 0.75
45 [Obstructive sleep apnea in patients with Parkinson's disease--report of two cases and review]. Laryngorhinootologie 2008 0.75
46 [Chemotherapy with paclitaxel leads to microRNA release]. HNO 2015 0.75
47 [Surgery of the parapharyngeal adenomas]. HNO 2007 0.75
48 TNFalpha contributes to the antitumor activity of a bispecific, trifunctional antibody. Anticancer Res 2002 0.75
49 [Brachytherapy in combination with function-preserving surgery of cancer of the paranasal sinus]. Laryngorhinootologie 2010 0.75
50 Targeting head and neck cancer by GM-CSF-mediated gene therapy in vitro. Anticancer Res 2000 0.75
51 [Posttraumatic gusher phenomenon following fracture of the petrous bone]. HNO 2008 0.75
52 [Jugular vein thrombosis caused by a neuroendocrine non-small cell lung cancer]. HNO 2010 0.75
53 [A prospective evaluation of psychometric items in patients with nasal deformities]. Laryngorhinootologie 2010 0.75
54 [Identification of CD11c+ myeloid dentritic cells in adenoids and in nasal mucosa of patients with and without allergies]. Laryngorhinootologie 2002 0.75
55 [Salivary gland stem cells : Can they restore radiation-induced salivary gland dysfunction?]. HNO 2010 0.75
56 [Acute hearing loss from scuba-diving holidays: diagnosis and treatment of barotrauma of the inner ear]. HNO 2009 0.75
57 Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia. Haematologica 2001 0.75
58 [Diagnosis and management of pain syndromes following parotidectomy]. HNO 2012 0.75
59 [Histomorphologic findings in the facial nerve after waterjet dissection of the parotid gland. Animal studies in dogs]. HNO 2011 0.75
60 [Structured residency training program for otolaryngology: a trendsetting principle]. HNO 2008 0.75
61 [Salivary gland carcinomas. 1. Epidemiology, etiology, malignancy criteria, prognostic parameters and classification]. HNO 2005 0.75
62 [Drooling following radiation. Botulinum toxin as a successful treatment modality]. HNO 2011 0.75
63 [Does the otorhinolaryngologist need Doppler sonography?]. Laryngorhinootologie 1992 0.75
64 [Dysplasia and laryngeal carcinoma in situ]. HNO 2012 0.75
65 [Cell-based strategies for salivary gland regeneration]. HNO 2008 0.75
66 [A rare cause of facial asymmetry: nasoalveolar cyst: a clinical report]. HNO 2008 0.75
67 [IL-2 gene therapy in ENT carcinomas]. Laryngorhinootologie 2001 0.75
68 [Infraorbital lesion after scuba diving with chronic sinusitis: diagnosis and treatment of reverse block]. HNO 2011 0.75
69 [Dyspnea caused by leiomyomatous tumor of the oropharynx]. Laryngorhinootologie 2001 0.75
70 [Histomorphologic findings in the facial nerve after water-jet dissection of the parotid gland in dogs]. HNO 2011 0.75
71 [The diagnosis of stages T1 and T2 in laryngeal carcinoma with multislice spiral CT]. Radiologe 1999 0.75
72 [Central sleep apnea in multiple sclerosis]. HNO 2010 0.75
73 [Recurring bilateral parotid swelling]. HNO 2003 0.75
74 [Patient satisfaction in the outpatient department--a pilot study for customer satisfaction in ENT]. HNO 2009 0.75